BNP PARIBAS FINANCIAL MARKETS - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$49,901
+50.4%
21,696
+138.7%
0.00%
Q2 2023$33,175
+9488.2%
9,089
+9270.1%
0.00%
Q1 2023$346
-36.2%
97
-48.9%
0.00%
Q4 2022$542
-99.9%
1900.0%0.00%
Q3 2022$424,000
-95.3%
190
-94.8%
0.00%
Q2 2022$9,016,000
-75.0%
3,621
-51.1%
0.00%
Q1 2022$36,117,000
-85.0%
7,401
-65.2%
0.00%
Q4 2021$240,835,000
+193.3%
21,294
+277.9%
0.00%
Q3 2021$82,102,000
+566.1%
5,635
+432.6%
0.00%
Q2 2021$12,326,000
-72.8%
1,058
-71.5%
0.00%
Q1 2021$45,238,000
+3.0%
3,708
+5.6%
0.00%
Q4 2020$43,923,000
-57.3%
3,511
-48.6%
0.00%
Q3 2020$102,822,000
+71.8%
6,832
+179.8%
0.00%
Q2 2020$59,853,000
-31.6%
2,442
-60.4%
0.00%
Q1 2020$87,467,000
+111.9%
6,164
+137.1%
0.00%
Q4 2019$41,275,000
+66.4%
2,600
-11.7%
0.00%
Q3 2019$24,809,000
+33.8%
2,943
+42.7%
0.00%
Q2 2019$18,546,000
-36.9%
2,063
-45.8%
0.00%
Q1 2019$29,413,000
+1972.8%
3,805
+1159.9%
0.00%
Q4 2018$1,419,000
-72.4%
302
-46.8%
0.00%
Q3 2018$5,140,000
-28.4%
568
-6.1%
0.00%
Q2 2018$7,175,000
-70.6%
605
-65.2%
0.00%
Q1 2018$24,405,0001,7370.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders